Cancer BiologybioRxiv
High-Dose Paclitaxel and its Combination with CSF1R Inhibitor in Polymeric Micelles for Chemoimmunotherapy of Triple Negative Breast Cancer
C. Lim, D. Hwang, M. Yazdimamaghani…·A. Kabanov
This study evaluates high-dose paclitaxel and its combination with CSF1R inhibitor in polymeric micelles for chemoimmunotherapy of triple-negative breast cancer, showing improved therapeutic outcomes and immune response.
DOI 10.1016/j.nantod.2023.101884